Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma

Carcinogenesis

Volumn 35, Issue 4, 2014, Pages 822-827

  Eckel Passow, Jeanette E ^a   Serie, Daniel J ^b   Bot, Brian M ^c   Joseph, Richard W ^b   Hart, Steven N ^a   Cheville, John C ^a   Parker, Alexander S ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c SAGE BIONETWORKS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VON HIPPEL LINDAU PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENRAGE GENE; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OBESITY; OVERALL SURVIVAL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SELF REPORT; SMOKING; UPREGULATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; OBESITY; POLYMERASE CHAIN REACTION; S100 PROTEINS;

EID: 84895919933     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt485     Document Type: Article

References (21)

1. Adams, K.F. et al. (2008) Body size and renal cell cancer incidence in a large US cohort study. Am. J. Epidemiol., 168, 268-277.
2. McGuire, B.B. et al. (2011) BMI and the risk of renal cell carcinoma. Curr. Opin. Urol., 21, 356-361.
3. Benichou, J. et al. (1998) Population attributable risk of renal cell cancer in Minnesota. Am. J. Epidemiol., 148, 424-430.
4. Brennan, P. et al. (2009) Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype. Int. J. Epidemiol., 38, 971-975.
5. Andreotii, G. et al. (2010) Variants in blood pressure genes and the risk of renal cell carcinoma. Carcinogenesis, 31, 614-620.
6. Shu, X. et al. (2013) Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk. J. Natl Cancer Inst., 105, 424-432.
7. Razzak, A.A. et al. (2012) Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study. Nutr. Cancer, 64, 899-910.
8. McCall, M.N. et al. (2010) Frozen robust multiarray analysis (fRMA). Biostatistics, 11, 242-253.
9. Bot, B.M. et al. (2012) Expression of endothelin 2 and localized clear cell renal cell carcinoma. Hum. Pathol., 43, 843-849.
10. Lipworth, L. et al. (2006) The epidemiology of renal cell carcinoma. J. Urol., 176(6 Pt 1), 2353-2358.
11. Goldfarb, S. et al. (1990) Morphology and anatomic localization of renal microneoplasms and proximal tubule dysplasias induced by four different estrogens in the hamster. Cancer Res., 50, 113-119.
12. Li, J.J. et al. (1999) Overexpression and amplification of c-myc in the Syrian hamster kidney during estrogen carcinogenesis: a probable critical role in neoplastic transformation. Cancer Res., 59, 2340-2346.
13. Scacchi, M. et al. (1999) Growth hormone in obesity. Int. J. Obes. Relat. Metab. Disord., 23, 260-271.
14. Moyad, M.A. (2001) Obesity, interrelated mechanisms, and exposures and kidney cancer. Semin. Urol. Oncol., 19, 270-279.
15. Gaens, K.H. et al. (2013) Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity. Curr. Opin. Lipidol., 24, 4-11.
16. Kessel, C. et al. (2013) Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers. Clin. Immunol., 147, 229-241.
17. Meijer, B. et al. (2012) The role of S100A12 as a systemic marker of inflammation. Int. J. Inflam., 2012, 907078.
18. Yamaoka, M. et al. (2013) Gene expression levels of S100 protein family in blood cells are associated with insulin resistance and inflammation (peripheral blood S100 mRNAs and metabolic syndrome). Biochem. Biophys. Res. Commun., 433, 450-455.
19. Barton, S.J. et al. (2013) Correction of unexpected distributions of P values from analysis of whole genome arrays by rectifying violation of statistical assumptions. BMC Genomics, 14, 161.
20. Lai, Y. et al. (2012) The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1. Arch. Biochem. Biophys., 518, 103-110.
21. Parker, A.S. et al. (2006) Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology, 68, 741-746.